Patients with posthemorrhagic hydrocephalus (PHH) from germinal matrix hemorrhage of prematurity often require numerous early interventions, as well as long-term follow-up care from pediatric neurosurgeons, which continues to place high demands on the existing workforce and pediatric health care system. There are established correlations between premature birth and low socioeconomic status. The aim of this study is to characterize the demographic profile and follow-up patterns in this subpopulation of surgically treated infants with PHH from prematurity. Methods: A retrospective analysis of the electronic patient records for a single institution, from 2007 to 2010, was performed. All patients who underwent neurosurgical intervention for the treatment of PHH were selected for further analysis. Data elements available within the records included patient demographic features, inpatient treatments and procedures, inpatient mortality rates, length of stay, and postoperative follow-up at the institution. Socioeconomic status was assessed using the median household income for the patient’s zip code, as reported in the United States Census for the year 2000. Results: A total of 40 patients who underwent neurosurgical intervention for PHH at a single institution were identified. More patients were female (52.5%); the majority of patients were Black (57.5%). No patients were uninsured; most patients had public insurance (62.5%), and 65% were below the Maryland State median household income (USD 52,868). There were trends toward more frequent emergency room visits among those covered by public insurance and those below the state and national median house income, although differences were not statistically significant. Conclusions: Our data indicate that the majority of patients fall within lower household income brackets, are born into households earning less than the statewide median household income, and are covered by public insurance. In light of the socioeconomic profile of the patient population reported here, these data may prove to be useful in preventative strategies aimed toward prematurity, PHH, and the ongoing treatment of hydrocephalus by pediatric neurosurgeons and other pediatric subspecialists.

Keywords:
Posthemorrhagic hydrocephalus, Germinal matrix hemorrhage, Pediatric neurosurgery, Socioeconomics
1.
Kulkarni AV, Cochrane DD, McNeely PD, Shams I: Medical, social, and economic factors associated with health-related quality of life in Canadian children with hydrocephalus. J Pediatr 2008;153:689–695.
2.
Ballabh P: Intraventricular hemorrhage in premature infants: mechanism of disease. Pediatr Res 2010;67:1–8.
3.
Blumenshine P, Egerter S, Barclay CJ, Cubbin C, Braveman PA: Socioeconomic disparities in adverse birth outcomes: a systematic review. Am J Prev Med;39:263–272.
4.
Smith LK, Draper ES, Manktelow BN, Dorling JS, Field DJ: Socioeconomic inequalities in very preterm birth rates. Arch Dis Child Fetal Neonatal Ed 2007;92:F11–F14.
5.
McCallum JE, Turbeville D: Cost and outcome in a series of shunted premature infants with intraventricular hemorrhage. Pediatr Neurosurg 1994;20:63–67.
6.
Pikus HJ, Levy ML, Gans W, Mendel E, McComb JG: Outcome, cost analysis, and long-term follow-up in preterm infants with massive grade IV germinal matrix hemorrhage and progressive hydrocephalus. Neurosurgery 1997;40:983–988; discussion 988–989.
7.
Durham SR, Lane JR, Shipman SA: The pediatric neurosurgical workforce: defining the current supply. Clinical article. J Neurosurg Pediatr 2009;3:1–10.
8.
Services USDoHaH: The pediatric rheumatology workforce: a study of the supply and demand for pediatric rheumatologists. Washington, Health Resources and Services Administration, 2007.
9.
Durham SR, Shipman SA: A 15-year review of pediatric neurosurgical fellowships: implications for the pediatric neurosurgical workforce. J Neurosurg Pediatr 2008;1:429–432.
10.
Iglehart JK: Expanding coverage for children – the democrats’ power and SCHIP reauthorization. N Engl J Med 2009;360:855–857.
11.
Szilagyi PG, Schuster MA, Cheng TL: The scientific evidence for child health insurance. Acad Pediatr 2009;9:4–6.
12.
Palfrey JS: How health care reform can benefit children and adolescents. N Engl J Med 2009;361:e34.
© 2012 S. Karger AG, Basel
2012
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.